166 related articles for article (PubMed ID: 12786827)
1. Expression of beta-catenin in basal cell carcinoma.
El-Bahrawy M; El-Masry N; Alison M; Poulsom R; Fallowfield M
Br J Dermatol; 2003 May; 148(5):964-70. PubMed ID: 12786827
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
Yamazaki F; Aragane Y; Kawada A; Tezuka T
Br J Dermatol; 2001 Nov; 145(5):771-7. PubMed ID: 11736900
[TBL] [Abstract][Full Text] [Related]
3. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
4. Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
Saldanha G; Ghura V; Potter L; Fletcher A
Br J Dermatol; 2004 Jul; 151(1):157-64. PubMed ID: 15270885
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinoma: a dermatopathological and molecular biological update.
Saldanha G; Fletcher A; Slater DN
Br J Dermatol; 2003 Feb; 148(2):195-202. PubMed ID: 12588368
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin expression in benign and malignant pilomatrix neoplasms.
Hassanein AM; Glanz SM
Br J Dermatol; 2004 Mar; 150(3):511-6. PubMed ID: 15030335
[TBL] [Abstract][Full Text] [Related]
7. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma.
Perez-Ordonez B; Huynh NN; Berean KW; Jordan RC
J Clin Pathol; 2004 Oct; 57(10):1080-3. PubMed ID: 15452164
[TBL] [Abstract][Full Text] [Related]
8. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model.
Sormunen RT; Leong AS; Vääräniemi JP; Fernando SS; Eskelinen SM
J Pathol; 1999 Mar; 187(4):416-23. PubMed ID: 10398100
[TBL] [Abstract][Full Text] [Related]
9. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
11. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
12. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.
Bartoš V; Kullová M
Acta Medica (Hradec Kralove); 2017; 60(1):32-36. PubMed ID: 28591550
[TBL] [Abstract][Full Text] [Related]
13. Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome.
Grabsch H; Takeno S; Noguchi T; Hommel G; Gabbert HE; Mueller W
Histopathology; 2001 Aug; 39(2):141-9. PubMed ID: 11493330
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin.
Haskell HD; Haynes HA; McKee PH; Redston M; Granter SR; Lazar AJ
J Cutan Pathol; 2005 Mar; 32(3):245-50. PubMed ID: 15701088
[TBL] [Abstract][Full Text] [Related]
15. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
Ramdial PK; Madaree A; Reddy R; Chetty R
J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
[TBL] [Abstract][Full Text] [Related]
17. Expression of beta-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma.
Boonchai W; Walsh M; Cummings M; Chenevix-Trench G
Arch Dermatol; 2000 Jul; 136(7):937-8. PubMed ID: 10891006
[No Abstract] [Full Text] [Related]
18. Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours.
Alami J; Williams BR; Yeger H
Mol Pathol; 2003 Aug; 56(4):218-25. PubMed ID: 12890743
[TBL] [Abstract][Full Text] [Related]
19. Comparison of PTCH1, COX-2, p53, and Ki-67 protein expression in basal cell carcinomas of nodular and superficial subtypes arising on the head and trunk.
Khalesi M; Waterhouse M; Whiteman DC; Johns R; Rosendahl C; Hackett T; Pollak T; Kimlin MG; Hacker E; Neale RE;
Int J Dermatol; 2016 Oct; 55(10):1096-105. PubMed ID: 27126210
[TBL] [Abstract][Full Text] [Related]
20. Expression of CXCR4, MMP-13 and β-catenin in different histological subtypes of facial basal cell carcinoma.
Ciurea ME; Cernea D; Georgescu CC; Cotoi OS; Pătraşcu V; Pârvănescu H; Popa D; Pârvănescu V; Ciurea RN; Mercuţ R
Rom J Morphol Embryol; 2013; 54(4):939-51. PubMed ID: 24398989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]